Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001387131-20-001217
Filing Date
2020-02-10
Accepted
2020-02-10 10:09:27
Documents
1
Group Members
ALTIUM GROWTH FUND, LPALTIUM GROWTH GP, LLC

Document Format Files

Seq Description Document Type Size
1 ACQUISITION OF BENEFICIAL OWNERSHIP catb-sc13g_013020.htm SC 13G 126613
  Complete submission text file 0001387131-20-001217.txt   128201
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Subject) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88910 | Film No.: 20590052
SIC: 2834 Pharmaceutical Preparations

Mailing Address 551 FIFTH AVE - FL 19 NEW YORK NY 10176
Business Address 551 FIFTH AVE - FL 19 NEW YORK NY 10176 2124842711
Altium Capital Management LP (Filed by) CIK: 0001746382 (see all company filings)

EIN.: 822066653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G